Prkd1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Prkd1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRKD2 Human Pre-designed siRNA Set A contains three designed siRNAs for PRKD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRKD3 Human Pre-designed siRNA Set A contains three designed siRNAs for PRKD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prkd3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prkd3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prkd3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Prkd3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRKDC Human Pre-designed siRNA Set A contains three designed siRNAs for PRKDC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prkdc Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prkdc gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prkdc Rat Pre-designed siRNA Set A contains three designed siRNAs for Prkdc gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRKG1 Human Pre-designed siRNA Set A contains three designed siRNAs for PRKG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRKG2 Human Pre-designed siRNA Set A contains three designed siRNAs for PRKG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRKN Human Pre-designed siRNA Set A contains three designed siRNAs for PRKN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRKRA Human Pre-designed siRNA Set A contains three designed siRNAs for PRKRA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRKRIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for PRKRIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRKX Human Pre-designed siRNA Set A contains three designed siRNAs for PRKX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRL Human Pre-designed siRNA Set A contains three designed siRNAs for PRL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRLH Human Pre-designed siRNA Set A contains three designed siRNAs for PRLH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRLHR Human Pre-designed siRNA Set A contains three designed siRNAs for PRLHR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRLR Human Pre-designed siRNA Set A contains three designed siRNAs for PRLR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRM1 Human Pre-designed siRNA Set A contains three designed siRNAs for PRM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRM2 Human Pre-designed siRNA Set A contains three designed siRNAs for PRM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRM3 Human Pre-designed siRNA Set A contains three designed siRNAs for PRM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for PRMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prmt1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Prmt1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRMT2 Human Pre-designed siRNA Set A contains three designed siRNAs for PRMT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRMT3 Human Pre-designed siRNA Set A contains three designed siRNAs for PRMT3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prmt3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Prmt3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRMT5 Human Pre-designed siRNA Set A contains three designed siRNAs for PRMT5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prmt5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Prmt5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRMT5-IN-35 (Compound 87) is a potent, selective and orally active PRMT5 inhibitor with an IC50 value of 1 nM . PRMT5-IN-35 can be used in cancer research[1].

PRMT5-IN-35 (Compound 87) is a potent, selective and orally active PRMT5 inhibitor with an IC50 value of 1 nM . PRMT5-IN-35 can be used in cancer research[1].

PRMT5-IN-35 (Compound 87) is a potent, selective and orally active PRMT5 inhibitor with an IC50 value of 1 nM . PRMT5-IN-35 can be used in cancer research[1].

PRMT5-IN-35 (Compound 87) is a potent, selective and orally active PRMT5 inhibitor with an IC50 value of 1 nM . PRMT5-IN-35 can be used in cancer research[1].

PRMT5-IN-35 (Compound 87) is a potent, selective and orally active PRMT5 inhibitor with an IC50 value of 1 nM . PRMT5-IN-35 can be used in cancer research[1].

PRMT5/EGFR-IN-1 (Compound 10p) is an orally active dual PRMT5/EGFR inhibitor, with IC50s of 15.47 and 19.31 μM, respectively. PRMT5/EGFR-IN-1 exhibits antiproliferative activity against A549, MCF7, HeLa, and MDA-MB-231 cell lines. PRMT5/EGFR-IN-1 has favorable in vivo PK and PD properties. PRMT5/EGFR-IN-1 can significantly inhibit the growth of MCF7 orthotopic xenograft tumors[1].

PRMT6 Human Pre-designed siRNA Set A contains three designed siRNAs for PRMT6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prmt6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRMT6 Rat Pre-designed siRNA Set A contains three designed siRNAs for PRMT6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRMT7 Human Pre-designed siRNA Set A contains three designed siRNAs for PRMT7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt7 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prmt7 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt7 Rat Pre-designed siRNA Set A contains three designed siRNAs for Prmt7 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRMT8 Human Pre-designed siRNA Set A contains three designed siRNAs for PRMT8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt8 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prmt8 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Prmt8 Rat Pre-designed siRNA Set A contains three designed siRNAs for Prmt8 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.